换一批Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).
第一作者：
L,Del Mastro
第一单位：
Department of Medical Oncology, National Cancer Research Institute, Largo Rosanna Benzi 10, 16132 Genoa, Italy. lucia.delmastro@istge.it
作者：
医学主题词
年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);乳腺肿瘤(Breast Neoplasms);疾病恶化(Disease Progression);女(雌)性(Female);心脏病(Heart Diseases);人类(Humans);输注, 静脉内(Infusions, Intravenous);中性粒细胞减少(Neutropenia);紫杉酚(Paclitaxel);存活率分析(Survival Analysis)
DOI
10.1093/annonc/mdi056
PMID
15668279
发布时间
2022-03-11
- 浏览2
Annals of oncology
253-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
